A. Rositch
John Hopkins Bloomberg School of Public Health Department of EpidemiologyDr. Anne F. Rositch is an applied epidemiologist, concentrating on cancer in women and global cancer disparities, with a background in basic science and experience conducting international field-based research. She received her PhD in Epidemiology from the University of North Carolina at Chapel Hill, and completed a post-doctoral fellowship in Cancer Epidemiology at Johns Hopkins. Currently, Dr. Rositch is an Associate Professor in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. For over 13 years, her research has focused on HPV and cervical cancer in HIV-positive individuals, aging women, and in low-resource settings. It has spanned the translational spectrum from epidemiological studies to understand the natural history of the disease, to studying the effectiveness and implementation of cervical cancer prevention in low-resource settings. Dr. Rositch has ongoing research in Baltimore, South America, and across sub-Saharan Africa. Her recent work is focused on leveraging her training in Implementation Science and experience in cervical cancer prevention to identify novel multidisciplinary and multilevel approaches for breast cancer control in low-resource settings.
Author Of 9 Presentations
IMPROVING CARE COMPLETION IN CERVICAL SCREENING BY MOVING FROM VIA SCREEN-AND-TRIAGE BY COLPOSCOPY PROGRAM TO AN HPV SCREEN-AND-TREAT PROGRAM IN IQUITOS, PERU: THE PROYECTO PRECANCER (ID 629)
Presenter
Lecture Time
06:13 PM - 06:25 PM
STAKEHOLDER ENGAGEMENT TO IDENTIFY AND ADOPT ACCEPTABLE, FEASIBLE, AND SUSTAINABLE STRATEGIES FOR CERVICAL CANCER PREVENTION (ID 246)
Presenter
Lecture Time
06:37 PM - 06:49 PM
IMPROVED SCREENING COVERAGE WHEN MOVING FROM VIA-BASED TO HPV-BASED SCREENING IN IQUITOS, PERU: THE PROYECTO PRECANCER (ID 479)
Presenter
Lecture Time
10:25 AM - 10:37 AM
EVIDENCE THAT CONCURRENT HPV16/18/45-POSITIVITY AND CYTOLOGIC "ATYPICAL GLANDULAR CELLS" IDENTIFIES AN EARLY PRECURSOR TO ADENOCARCINOMA OF THE CERVIX (ID 594)
Presenter
Lecture Time
06:15 AM - 06:20 AM
Moderated panel discussion (ID 1180)
Lecture Time
06:47 AM - 07:27 AM
EXPERIENCE AND ASSESSMENT OF ELECTRONIC SCREENING REGISTRY DEVELOPMENT FOR CERVICAL CANCER PROGRAM MONITORING AND EVALUATION (ID 476)
Presenter
Lecture Time
07:25 AM - 07:30 AM
Conclusions, follow-up and acknowledgements (ID 1182)
Presenter
Lecture Time
07:27 AM - 07:32 AM
IMPACT OF COVID-19 ON IMPLEMENTATION OF A NEW HPV SCREEN-AND-TREAT PROGRAM IN IQUITOS, PERU (ID 480)
Presenter
Lecture Time
07:00 AM - 07:05 AM
Presenter of 4 Presentations
Moderated panel discussion (ID 1180)
Lecture Time
06:47 AM - 07:27 AM
Conclusions, follow-up and acknowledgements (ID 1182)
Presenter
Lecture Time
07:27 AM - 07:32 AM
STAKEHOLDER ENGAGEMENT TO IDENTIFY AND ADOPT ACCEPTABLE, FEASIBLE, AND SUSTAINABLE STRATEGIES FOR CERVICAL CANCER PREVENTION (ID 246)
Presenter
Lecture Time
06:37 PM - 06:49 PM
Moderator of 1 Session
Session Type
Special Interest Satellite Symposium
Date
Tue, Nov 16, 2021
Session Time
06:00 AM - 11:00 PM
Chair(s)